Zimmer Biomet Holdings, Inc. ZBH

Full chart Compare
Set alert

Price alert · ZBH

All alert types
97.06 USD -0.29 (-0.30%)

At closeNov 3, 2026, 5:24 PM EST

97.00 -0.06 -0.06%

After hours · Nov 3, 5:24 PM ET

96.07 Day range 97.82
79.12 52-week range 103.70
YTD
+7.94%
1 year
-2.82%
Market cap
18.51B
Revenue (ttm)
8.51B
Profit margin
9.48%
EPS (ttm)
4.12
Shares out
190.74M
P/E ratio
23.56
Forward P/E
10.72
Dividend
0.96 (0.99%)
Ex-dividend date
Sep 29, 2026
YTD return
+7.94%
1-year return
-2.82%
Volume
3.03M
Avg volume
2.09M
Open
96.49
Previous close
97.35
Day's range
96.07 – 97.82
52-week range
79.12 – 103.70
Beta
0.47
Analysts
Buy
Price target
106.90 (+10.1%)
Earnings date
Nov 4, 2026

5m +0.84 (+0.87%)

95969798Oct 28Oct 29Oct 30Nov 2Nov 397.16

Key statistics

Enterprise value
25.71B
PEG ratio
0.61
Price / sales
2.18
Price / book
1.47
Dividend yield
0.99%
Payout ratio
23.30%
Revenue growth
4.80%
Free cash flow
1.07B
Total cash
464.50M
Total debt
7.60B
Return on equity
6.41%
Short % of float
5.51%
50-day average
94.77
200-day average
91.67

Financials — quick view

All financials
ZBH Revenue — quarterly 2.18B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH Net income — quarterly 198.30M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH EPS — quarterly 1.03
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ZBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20261.88———
Aug 5, 2026Jun 30, 20262.012.07+0.06+2.99%
Apr 28, 2026Mar 31, 20261.862.09+0.23+12.37%
Feb 10, 2026Dec 31, 20252.382.42+0.04+1.68%
Nov 5, 2025Sep 30, 20251.871.90+0.03+1.60%
Aug 7, 2025Jun 30, 20251.982.07+0.09+4.55%

Upgrades / downgrades

ZBH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 22, 2026Argus ResearchreitBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Aug 10, 2026Canaccord GenuitymainHoldHold
Aug 7, 2026Truist SecuritiesmainHoldHold
Aug 6, 2026RBC CapitalmainOutperformOutperform
Aug 6, 2026BernsteinmainMarket PerformMarket Perform

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ZBH — it syncs with the Stock Master app.

Insider holders

ZBH insider holders
InsiderRelationLatest transactionDateShares held
BEZJAK MARKOfficerConversion of Exercise of derivative securityMar 5, 202513,134
ELLINGSON RACHEL H.OfficerConversion of Exercise of derivative securityFeb 19, 202511,906
NOOR JEHANZEBOfficerConversion of Exercise of derivative securityMar 31, 20265,151
PHIPPS CHAD FOfficerSaleSep 3, 202665,231
STELLATO PAUL AOfficerConversion of Exercise of derivative securityMar 5, 20265,582
TORNOS IVANChief Executive OfficerConversion of Exercise of derivative securityMar 5, 202683,191

Institution ownership

ZBH institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.12.65%24,124,7352.34BJun 29, 2026
Blackrock Inc.8.19%15,614,8471.52BJun 29, 2026
Harris Associates L.P.6.68%12,738,0251.24BJun 29, 2026
Vanguard Capital Management LLC6.62%12,634,9371.23BJun 29, 2026
Capital International Investors6.39%12,183,6141.18BJun 29, 2026
State Street Corporation4.65%8,877,171861.40MJun 29, 2026

Fund ownership

ZBH fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.15%15,549,9001.51BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%6,141,461595.94MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund3.08%5,867,350569.34MJul 30, 2026
HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Fund2.95%5,621,292545.46MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%5,010,793486.22MJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.42%4,610,277447.36MSep 29, 2026